TipRanks
Incyte Corp (DE:ICY)
XETRA:ICY
Germany Market
ICY
Incyte
RESEARCH TOOLSreports

Incyte (ICY) Stock News & Sentiment

4 Followers
Incyte Buy Rating Reiterated as KRAS G12D Asset Shows Differentiated Efficacy; $152 Price Target Maintained
Premium
Ratings
Incyte Buy Rating Reiterated as KRAS G12D Asset Shows Differentiated Efficacy; $152 Price Target Maintained
8h ago
INCY
Incyte’s Latest Dermal PK Study: What Completed Early-Stage Data Mean for INCY Investors
Premium
Company Announcements
Incyte’s Latest Dermal PK Study: What Completed Early-Stage Data Mean for INCY Investors
4d ago
INCY
Incyte’s KRAS G12D Lead Supports Undervalued Upside as Kapoor Reiterates Buy and Maintains $152 Price Target
Premium
Ratings
Incyte’s KRAS G12D Lead Supports Undervalued Upside as Kapoor Reiterates Buy and Maintains $152 Price Target
14d ago
INCY
Incyte: Atebrioz Approval and KRAS Pipeline Upside Drive Buy Rating; Price Target Raised to $152
Premium
Ratings
Incyte: Atebrioz Approval and KRAS Pipeline Upside Drive Buy Rating; Price Target Raised to $152
15d ago
INCY
AFLAC, CME, Incyte, Box, Five Below Insider Shake-Up
Premium
Weekend Updates
AFLAC, CME, Incyte, Box, Five Below Insider Shake-Up
24d ago
AFL
BOX
Incyte Reaches CMS Pact on Jakafi Medicaid Pricing
Premium
Company Announcements
Incyte Reaches CMS Pact on Jakafi Medicaid Pricing
1M ago
8K
INCY
Buy Rating Reaffirmed on Incyte as ‘734 Pancreatic Cancer Data Looms; 12-Month Price Target Reiterated at $150
Premium
Ratings
Buy Rating Reaffirmed on Incyte as ‘734 Pancreatic Cancer Data Looms; 12-Month Price Target Reiterated at $150
2M ago
INCY
More DE:ICY News >

ICY News on the Web

Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA), Xeris Pharmaceuticals (XERS) and Incyte (INCY)
TipRanks News
Bullish
BAKER BROS. ADVISORS LP Expands Stake in Kodiak Sciences Inc (KOD) with 2.13 Million Share Purchase
GuruFocus News
Neutral
BAKER BROS. ADVISORS LP Expands Stake in Kodiak Sciences Inc (KOD) with 1.13 Million Share Purchase
GuruFocus News
Neutral
FDA Expands Lilly's Olumiant Approval To Adolescents With Severe Alopecia Areata
rttnews
Bullish
Incyte (INCY) Gets a Hold from Bernstein
TipRanks News
Neutral
FDA approves Incyte’s Atebrioz for fibrodysplasia ossificans progressiva
TipRanks News
Bullish
Incyte Expands OPZELURA Partnership With Specialised Therapeutics In Australia
rttnews
Bullish
Specialised Therapeutics expands partnership with Incyte to include Opzelura
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
DE:ICY
Sector Average
Media Buzz
This Week3 articles
Weekly Average8.25 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:ICY’s Media Buzz Sentiment?
3 articles about DE:ICY were published this week. In an average week, 8.25 articles are published.
    What is DE:ICY’s weekly average amount of articles?
    In an average week, 8.25 articles about DE:ICY are published.
      What is DE:ICY’s News Sentiment?
      100% of articles about DE:ICY were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        IQVIQVIA Holdings
        GILDGilead Sciences
        ABBVAbbVie
        VRTXVertex Pharmaceuticals
        NVSNovartis
        Showing the stocks with the most bullish news sentiment over the past week